Cargando…
Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk
This article is about risk. Risk is probably the most misunderstood component in determining therapeutic intervention; however, it is probably the most relevant issue to consider in the context of expected benefit. The rarity of quantitative risk–benefit assessment and the lack of comparative risk–b...
Autores principales: | Goldkind, Lawrence, Simon, Lee S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526603/ https://www.ncbi.nlm.nih.gov/pubmed/16542490 http://dx.doi.org/10.1186/ar1924 |
Ejemplares similares
-
Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?
por: Yeomans, Neville D
Publicado: (2015) -
Nonsteroidal Anti-Inflammatory Drugs, Gastroprotection, and Benefit–Risk
por: Moore, Robert Andrew, et al.
Publicado: (2014) -
Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
por: Jeter, Joanne M., et al.
Publicado: (2011) -
Nonsteroidal anti-inflammatory drugs and their risk: a story still in development
por: Simon, Lee S
Publicado: (2013) -
Risk of stroke associated with nonsteroidal anti-inflammatory drugs
por: Park, Ki, et al.
Publicado: (2014)